2,306
Views
0
CrossRef citations to date
0
Altmetric
Review

Telomere Therapy for Chronic Kidney Disease

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1039-1054 | Received 02 Mar 2022, Accepted 25 Jul 2022, Published online: 30 Sep 2022

References

  • Gekle M . Kidney and aging-a narrative review. Exp. Gerontol.87, 153–155 (2017).
  • Glassock RJ , RuleAD. Aging and the kidneys: anatomy, physiology and consequences for defining chronic kidney disease. Nephron134(1), 25–29 (2016).
  • Levey AS , EckardtK-U , DormanNMet al. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int.97(6), 1117–1129 (2020).
  • Eckardt K-U , CoreshJ , DevuystOet al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet382(9887), 158–169 (2013).
  • Jha V , Garcia-GarciaG , IsekiKet al. Chronic kidney disease: global dimension and perspectives. Lancet382(9888), 260–272 (2013).
  • Jager KJ , KovesdyC , LanghamR , RosenbergM , JhaV , ZoccaliC. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int.34(11), 1803–1805 (2019).
  • Bikbov B , PurcellCA , LeveyASet al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet395(10225), 709–733 (2020).
  • Zhang J , ThioCH , GansevoortRT , SniederH. Familial aggregation of CKD and heritability of kidney biomarkers in the general population: the Lifelines Cohort Study. Am. J. Kidney Dis.77(6), 869–878 (2021).
  • Debiec R , ChristofidouP , DenniffMet al. Urotensin-II system in genetic control of blood pressure and renal function. PLOS ONE8(12), e83137 (2013).
  • Levin A , StevensPE , BilousRWet al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl.3(1), 1–150 (2013).
  • Peng SY , HeJW , HuangJSet al. Self-management interventions for chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol.20(1), 142 (2019).
  • Keith DS , NicholsGA , GullionCM , BrownJB , SmithDH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch. Intern. Med.164(6), 659–663 (2004).
  • Kazancioğlu R . Risk factors for chronic kidney disease: an update. Kidney Int. Suppl.3(4), 368–371 (2013).
  • Allshire RC , DempsterM , HastieND. Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res.17(12), 4611–4627 (1989).
  • Bajaj S , KumarMS , PetersGJ , MayurYC. Targeting telomerase for its advent in cancer therapeutics. Med. Res. Rev.40(5), 1871–1919 (2020).
  • Griffith JD , ComeauL , RosenfieldSet al. Mammalian telomeres end in a large duplex loop. Cell97(4), 503–514 (1999).
  • Stewart JA , ChaikenMF , WangF , PriceCM. Maintaining the end: roles of telomere proteins in end-protection, telomere replication and length regulation. Mutat. Res.730(1-2), 12–19 (2012).
  • Levy MZ , AllsoppRC , FutcherAB , GreiderCW , HarleyCB. Telomere end-replication problem and cell aging. J. Mol. Biol.225(4), 951–960 (1992).
  • Lormand JD , BuncherN , MurphyCTet al. DNA polymerase δ stalls on telomeric lagging strand templates independently from G-quadruplex formation. Nucleic Acids Res.41(22), 10323–10333 (2013).
  • Wright WE , ShayJW. Telomere biology in aging and cancer. J. Am. Geriatr. Soc.53(Suppl. 9), S292–S294 (2005).
  • D’souza Y , LauzonC , ChuTW , AutexierC. Regulation of telomere length and homeostasis by telomerase enzyme processivity. J. Cell Sci.126(2), 676–687 (2013).
  • Hayflick L , MoorheadPS. The serial cultivation of human diploid cell strains. Exp. Cell Res.25(3), 585–621 (1961).
  • Jacobs JJ , DeLange T. Significant role for p16INK4a in p53-independent telomere-directed senescence. Curr. Biol.14(24), 2302–2308 (2004).
  • Jiang J , ChanH , CashDDet al. Structure of Tetrahymena telomerase reveals previously unknown subunits, functions, and interactions. Science350(6260), (2015).
  • Nguyen THD , TamJ , WuRAet al. Cryo-EM structure of substrate-bound human telomerase holoenzyme. Nature557(7704), 190–195 (2018).
  • Oeseburg H , DeBoer RA , Van GilstWH , VanDer Harst P. Telomere biology in healthy aging and disease. Pflugers Arch.459(2), 259–268 (2010).
  • Blackburn EH , EpelES , LinJ. Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science350(6265), 1193–1198 (2015).
  • Saretzki G . Telomeres, telomerase and ageing. Biochem. Cell Biol. Aging90, 221–308 (2018).
  • Von Zglinicki T . Oxidative stress shortens telomeres. Trends Biochem. Sci.27(7), 339–344 (2002).
  • Kawanishi S , OikawaS. Mechanism of telomere shortening by oxidative stress. Ann. NY Acad. Sci.1019(1), 278–284 (2004).
  • Jurk D , WilsonC , PassosJFet al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun.5(1), 1–14 (2014).
  • Zhang J , RaneG , DaiXet al. Ageing and the telomere connection: an intimate relationship with inflammation. Aging Res. Rev.25, 55–69 (2016).
  • Saraswati S , MartínezP , Graña-CastroO , BlascoMA. Short and dysfunctional telomeres sensitize the kidneys to develop fibrosis. Nat. Aging1(3), 269–283 (2021).
  • Galati A , MicheliE , CacchioneS. Chromatin structure in telomere dynamics. Front. Oncol.3, 46 (2013).
  • Aguado J , DiFagagna FDA , WolvetangE. Telomere transcription in ageing. Aging Res. Rev.62, 101115 (2020).
  • Porro A , FeuerhahnS , DelafontaineJ , RiethmanH , RougemontJ , LingnerJ. Functional characterization of the TERRA transcriptome at damaged telomeres. Nat. Commun.5(1), 1–13 (2014).
  • Lin J , JiangZ , LiuCet al. Emerging roles of long non-coding RNAs in renal fibrosis. Life10(8), 131 (2020).
  • El-Desoky MM , HewidyAA , FoudaAM , HishamFA. Telomeric repeat-containing ribonucleic acid (TERRA) expression in patients with idiopathic pulmonary fibrosis. Egypt. J. Med. Hum. Genet.22(1), 1–9 (2021).
  • Westhoff JH , SchildhornC , JacobiCet al. Telomere shortening reduces regenerative capacity after acute kidney injury. J. Am. Soc. Nephrol.21(2), 327–336 (2010).
  • Cheng HF , FanXF , LawsonWE , PaueksakonP , HarrisRC. Telomerase deficiency delays renal recovery in mice after ischemia-reperfusion injury by impairing autophagy. Kidney Int.88(1), 85–94 (2015).
  • Wong LS , WindtWA , RoksAJet al. Renal failure induces telomere shortening in the rat heart. Neth. Heart J.17(5), 190–194 (2009).
  • Quimby JM , MaranonDG , BattagliaCLR , MclelandSM , BrockWT , BaileySM. Feline chronic kidney disease is associated with shortened telomeres and increased cellular senescence. Am. J. Physiol. Renal Physiol.305(3), F295–F303 (2013).
  • Quimby J , EricksonA , MclelandSet al. Renal senescence, telomere shortening and nitrosative stress in feline chronic kidney disease. Vet. Sci.8(12), 314 (2021).
  • Raeisi S , GhorbanihaghjoA , ArganiHet al. Oxidative stress-induced renal telomere shortening as a mechanism of cyclosporine-induced nephrotoxicity. J. Biochem. Mol. Toxicol.32(8), e22166 (2018).
  • Carracedo J , BuendiaP , MerinoAet al. Cellular senescence determines endothelial cell damage induced by uremia. Exp. Gerontol.48(8), 766–773 (2013).
  • Betjes MGH , LangerakAW , VanDer Spek A , DeWit EA , LitjensNHR. Premature aging of circulating T cells in patients with end-stage renal disease. Kidney Int.80(2), 208–217 (2011).
  • Kato S , ShielsPG , McguinnessDet al. Telomere attrition and elongation after chronic dialysis initiation in patients with end-stage renal disease. Blood Purif.41(1-3), 25–33 (2016).
  • Gurung RL , YiamunaaM , LiuS , LiuJJ , LimSC , StudySD. Short leukocyte telomere length predicts albuminuria progression in individuals with Type 2 diabetes. Kidney Int. Rep.3(3), 592–601 (2018).
  • Raschenberger J , KolleritsB , TitzeSet al. Do telomeres have a higher plasticity than thought? Results from the German Chronic Kidney Disease (GCKD) study as a high-risk population. Exp. Gerontol.72, 162–166 (2015).
  • Crepin T , LegendreM , CarronCet al. Uraemia-induced immune senescence and clinical outcomes in chronic kidney disease patients. Nephrol. Dial. Transplant.35(4), 624–632 (2018).
  • Fazzini F , LaminaC , RaschenbergerJet al. Results from the German Chronic Kidney Disease (GCKD) study support association of relative telomere length with mortality in a large cohort of patients with moderate chronic kidney disease. Kidney Int.98(2), 488–497 (2020).
  • Stefanidis I , VoliotisG , PapanikolaouVet al. Telomere length in peripheral blood mononuclear cells of patients on chronic hemodialysis is related with telomerase activity and treatment duration. Artif. Organs39(9), 756–764 (2015).
  • Ramírez R , CarracedoJ , SorianoSet al. Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis. Am. J. Kidney Dis.45(2), 353–359 (2005).
  • Carrero JJ , StenvinkelP , FellstromBet al. Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J. Intern. Med.263(3), 302–312 (2008).
  • Borras M , PanizoS , SarroF , ValdivielsoJM , FernandezE. Assessment of the potential role of active vitamin D treatment in telomere length: a case-control study in hemodialysis patients. Clin. Ther.34(4), 849–856 (2012).
  • Luttropp K , NordforsL , McguinnessDet al. Increased telomere attrition after renal transplantation-impact of antimetabolite therapy. Transplant. Direct2(12), e116 (2016).
  • Petrara MR , SerrainoD , DiBella Cet al. Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: impact of mTOR inhibitors. Cancer Lett.469, 323–331 (2020).
  • Meijers RWJ , LitjensNHR , DeWit EA , LangerakAW , BaanCC , BetjesMGH. Uremia-associated immunological aging is stably imprinted in the T-cell system and not reversed by kidney transplantation. Transpl. Int.27(12), 1272–1284 (2014).
  • Tentolouris N , NzietchuengR , CattanVet al. White blood cells telomere length is shorter in males with type 2 diabetes and microalbuminuria. Diabetes Care30(11), 2909–2915 (2007).
  • Fyhrquist F , TiituA , SaijonmaaO , ForsblomC , GroopPH. Finndiane Study G. Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes. J. Intern. Med.267(3), 278–286 (2010).
  • Van Der Harst P , WongLSM , DeBoer RAet al. Possible association between telomere length and renal dysfunction in patients with chronic heart failure. Am. J. Cardiol.102(2), 207–210 (2008).
  • Wong LSM , VanDer Harst P , DeBoer RAet al. Renal dysfunction is associated with shorter telomere length in heart failure. Clin. Res. Cardiol.98(10), 629–634 (2009).
  • Mazidi M , RezaieP , CovicAet al. Telomere attrition, kidney function, and prevalent chronic kidney disease in the United States. Oncotarget8(46), 80175–80181 (2017).
  • Cao DW , JiangCM , WanCet al. Upregulation of MiR-126 delays the senescence of human glomerular mesangial cells induced by high glucose via telomere-p53-p21-Rb signaling pathway. Curr. Med. Sci.38(5), 758–764 (2018).
  • Raschenberger J , KolleritsB , RitchieJet al. Association of relative telomere length with progression of chronic kidney disease in two cohorts: effect modification by smoking and diabetes. Sci. Rep.5, 11887 (2015).
  • De Vusser K , PietersN , JanssenBet al. Telomere length, cardiovascular risk and arteriosclerosis in human kidneys: an observational cohort study. Aging7(10), 766–775 (2015).
  • De Vusser K , MartensD , LerutE , KuypersD , NawrotTS , NaesensM. Replicative senescence and arteriosclerosis after kidney transplantation. Nephrol. Dial. Transplant.35(11), 1984–1995 (2020).
  • Raschenberger J , KolleritsB , TitzeSet al. Association of relative telomere length with cardiovascular disease in a large chronic kidney disease cohort: The GCKD study. Atherosclerosis242(2), 529–534 (2015).
  • Bansal N , WhooleyMA , ReganMet al. Association between kidney function and telomere length: the heart and soul study. Am. J. Nephrol.36(5), 405–411 (2012).
  • Park S , LeeS , KimYet al. A Mendelian randomization study found causal linkage between telomere attrition and chronic kidney disease. Kidney Int.100(5), 1063–1070 (2021).
  • Zhang WG , WangY , HouKet al. A correlation study of telomere length in peripheral blood leukocytes and kidney function with age. Mol. Med. Rep.11(6), 4359–4364 (2015).
  • Eguchi K , HonigLS , LeeJH , HoshideS , KarioK. Short telomere length is associated with renal impairment in Japanese subjects with cardiovascular risk. PLOS ONE12(4), e0176138 (2017).
  • Pykhtina VS , StrazheskoID , TkachevaONet al. Association of renal function, telomere length, and markers of chronic inflammation in patients without chronic kidney and cardiovascular diseases. Adv. Gerontol.6(3), 217–223 (2016).
  • Ma C , HeS , LiP , ZhangH , LiW , LiY. Negative association between caloric intake and estimated glomerular filtration rate in a chinese population: mediation models involving mitochondrial function. Gerontology66(5), 439–446 (2020).
  • Zhang WG , JiaLP , MaJet al. Peripheral blood leukocyte telomere length is associated with age but not renal function: a cross-sectional follow-up study. J. Nutr. Health Aging22(2), 276–281 (2018).
  • Kidir V , AynaliA , AltuntasA , InalS , AridoganB , SezerMT. Telomerase activity in patients with stage 2-5D chronic kidney disease. Nefrologia37(6), 592–597 (2017).
  • Kordinas V , TsirpanlisG , NicolaouCet al. Is there a connection between inflammation, telomerase activity and the transcriptional status of telomerase reverse transcriptase in renal failure? Cell. Mol. Biol. Lett. 20(2), 222–236 (2015).
  • Tsirpanlis G , ChatzipanagiotouS , BoufidouFet al. Telomerase activity is decreased in peripheral blood mononuclear cells of hemodialysis patients. Am. J. Nephrol.26(1), 91–96 (2006).
  • Demanelis K , JasmineF , ChenLSet al. Determinants of telomere length across human tissues. Science369(6509), (2020).
  • Bar C , DeJesus BB , SerranoRet al. Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction. Nat. Commun.5, 5863 (2014).
  • Zhang H , LiY , SongYJCPJ. Effect of polysaccharides of Cistanche deserticola on immune cells and telomerase activity in aging mice. J. Chin. Pharm. Sci.46(14), 1081–1083 (2011).
  • Bernardes De Jesus B , VeraE , SchneebergerKet al. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol. Med.4(8), 691–704 (2012).
  • Harley CB , LiuW , BlascoMet al. A natural product telomerase activator as part of a health maintenance program. Rejuvenation Res.14(1), 45–56 (2011).
  • Salvador L , SingaraveluG , HarleyCB , FlomP , SuramA , RaffaeleJM. A natural product telomerase activator lengthens telomeres in humans: a randomized, double blind, and placebo controlled study. Rejuvenation Res.19(6), 478–484 (2016).
  • Dong XX , HuiZJ , XiangWX , RongZF , JianS , ZhuCJ. Ginkgo biloba extract reduces endothelial progenitor-cell senescence through augmentation of telomerase activity. J. Cardiovasc. Pharmacol.49(2), 111–115 (2007).
  • Raguraman V , SubramaniamJR. Withania somnifera root extract enhances telomerase activity in the human HeLa cell line. Biotechnology7(4), 199–204 (2016).
  • Cantrell LA , ZhouC , MendivilA , MalloyKM , GehrigPA , Bae-JumpVL. Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy. Gynecol. Oncol.116(1), 92–98 (2010).
  • Hanna RK , ZhouC , MalloyKMet al. Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway. Gynecol. Oncol.125(2), 458–469 (2012).
  • Javidfar S , Pilehvar-SoltanahmadiY , FarajzadehRet al. The inhibitory effects of nano-encapsulated metformin on growth and hTERT expression in breast cancer cells. J. Drug Deliv. Sci. Technol.43, 19–26 (2018).
  • Ma DL , YuY , YuXF , ZhangMX , YangY. The changes of leukocyte telomere length and telomerase activity after sitagliptin intervention in newly diagnosed type 2 diabetes. Diabetes Metab. Res. Rev.31(3), 256–261 (2015).
  • Liu JH , GeYL , WuSet al. Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes. Aging11(2), 741–755 (2019).
  • Zeng JB , LiuHB , PingF , LiW , LiYX. Insulin treatment affects leukocyte telomere length in patients with type 2 diabetes: 6-year longitudinal study. J. Diabetes Complications33(5), 363–367 (2019).
  • Chiu CL , HearnNL , PaineD , SteinerN , LindJM. Does telomere shortening precede the onset of hypertension in spontaneously hypertensive mice?Twin Res. Hum. Genet.19(5), 422–429 (2016).
  • Baumann M , BartholomeR , Peutz-KootstraCJ , SmitsJFM , Struijker-BoudierHaJ. Sustained tubulo-interstitial protection in SHRs by transient losartan treatment: an effect of decelerated aging?Am. J. Hypertens.21(2), 177–182 (2008).
  • Zhang S , LiR , YangYet al. Longitudinal association of telomere attrition with the effects of antihypertensive treatment and blood pressure lowering. Aging Dis.11(3), 494–508 (2020).
  • Dudinskaya EN , TkachevaON , BazaevaEVet al. New possibilities of using moxonidin for blood pressure control in female patients with osteopenia. Kardiologiya58, 36–45 (2018).
  • Martynowicz H , GaćP , Kornafel-FlakOet al. The relationship between the effectiveness of blood pressure control and telomerase reverse transcriptase concentration, adipose tissue hormone concentration and endothelium function in hypertensives. Heart Lung Circ.29(8), e200–e209 (2020).
  • Guterres AN , VillanuevaJ. Targeting telomerase for cancer therapy. Oncogene39(36), 5811–5824 (2020).
  • Schrank Z , KhanN , OsudeCet al. Oligonucleotides targeting telomeres and telomerase in cancer. Molecules23(9), (2018).
  • Kim SR , JiangK , OgrodnikMet al. Increased renal cellular senescence in murine high-fat diet: effect of the senolytic drug quercetin. Transl. Res.213, 112–123 (2019).
  • Hickson LJ , PrataLGL , BobartSAet al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. EBioMedicine47, 446–456 (2019).
  • Miao L , LiuC , GeJet al. Antitumor effect of TRAIL on oral squamous cell carcinoma using magnetic nanoparticle-mediated gene expression. Cell Biochem. Biophys.69(3), 663–672 (2014).
  • Liu Z , ZhaoJ , ZhangRet al. Cross-platform cancer cell identification using telomerase-specific spherical nucleic acids. ACS Nano12(4), 3629–3637 (2018).
  • Wu YH , ZhongD , LiYHet al. Tumor-oriented telomerase-terminated nanoplatform as versatile strategy for multidrug resistance reversal in cancer treatment. Adv. Healthc. Mater.9(7), (2020).
  • Wu Y , ZhongD , LiYet al. A tumor-activatable peptide supramolecular nanoplatform for the delivery of dual-gene targeted siRNAs for drug-resistant cancer treatment. Nanoscale13(9), 4887–4898 (2021).
  • Wu LL , FidanK , UmJY , AhnKS. Telomerase: key regulator of inflammation and cancer. Pharmacol. Res.155, 104726 (2020).